eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
4/2017
vol. 68
 
Share:
Send email
Share:
abstract:
Original paper

Clinical significance of nestin and its association with survival in neuroendocrine lung tumours

Barbara Brominska
,
Piotr Gabryel
,
Donata Jarmołowska-Jurczyszyn
,
Małgorzata Janicka-Jedyńska
,
Maciej Trojanowski
,
Nadia Sawicka-Gutaj
,
Rafał Czepczyński
,
Paweł Gut
,
Gabriel Bromiński
,
Wojciech Dyszkiewicz
,
Aldona Woźniak
,
Marek Ruchała

Pol J Pathol 2017; 68 (4): 291-296
DOI: https://doi.org/10.5114/pjp.2017.73924
Online publish date: 2018/03/06
View full text Get citation
 
PlumX metrics:
Nestin is considered to be a cancer stem cell marker. Nestin expression in neuroendocrine tumours might be useful to predict prognosis and facilitate treatment planning. 88 patients with neuroendocrine lung tumours operated in the Department of Thoracic Surgery from 2007 to 2015 were included into the study. Immunohistochemical staining for nestin was performed. Clinicopathological and survival data were retrospectively analyzed. Nestin expression was detected in 15 (17%) specimens. Multivariate analysis showed that lymph node metastases (p = 0.0001; hazard ratio (HR) = 3.93; confidence interval (CI) 95%: 1.96-7.87), nestin expression (p = 0.034; HR = 2.30; CI 95%: 1.06-4.99) and patient’s age (p = 0.024; HR = 1.04; CI 95%: 1.00-1.09) were independent negative prognostic factors. Nestin expression was significantly higher in large cell neuroendocrine carcinoma when compared with carcinoids (p = 0.001). Collected data support the thesis that nestin can be regarded as a biomarker in patients with neuroendocrine lung tumours.
keywords:

neuroendocrine markers, neuroendocrine tumours, pulmonary pathology
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.